Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.
Authors: Talley RW, O'Bryan RM, Burrows JH, San Diego EL
Source: Cancer chemotherapy reports [Cancer Chemother Rep] 1970 Aug; Vol. 54 (4), pp. 249-53.
Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article
Journal Info: Publisher: National Cancer Institute [etc.] Country of Publication: United States NLM ID: 7607105 Publication Model: Print Cited Medium: Print ISSN: 0069-0112 (Print) Linking ISSN: 00690112 NLM ISO Abbreviation: Cancer Chemother Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0069-0112